Pathogenesis and Novel Therapies in Epithelial Cancers
A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cellular Pathology".
Deadline for manuscript submissions: 30 June 2025 | Viewed by 136
Special Issue Editors
Interests: functional genomics; prostate cancer; lung cancer; small-cell cancer; neuroendocrine cancer; genetically engineered disease model; transcriptome; epigenetics
Special Issue Information
Dear Colleagues,
Cancers can develop in various epithelial tissues. The most common types of epithelial cancers are breast cancer, prostate cancer, lung cancer, colorectal cancer, and skin cancer. Despite recent advancements in therapeutic strategies, such as targeted therapy, antibody–drug conjugates, CAR-T immunotherapy, nanoparticle-based drug delivery, and personalized medicine, these cancers remain life-threatening. Therefore, addressing how human epithelial cancers are initiated, developed, and differentiated, and the molecular factors behind them, can allow us to identify molecular vulnerabilities and utilize advanced therapeutic strategies to treat cancer patients efficiently. This can provide new insights into the genetic alterations, epigenetic mechanisms, metabolic changes, and immune system factors that contribute to cancer initiation, development, and progression. This Special Issue will highlight recent advancements and future directions in epithelial cancer research. We invite the submission of original articles and reviews on molecular mechanisms, diagnostics, therapeutic advances, and translational research, combining basic research with clinical applications.
Dr. Jung Wook Park
Dr. Sanjeevram Dhandapani
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- transformation
- malignant
- oncogene
- tumor suppressor
- molecular mechanisms
- epigenetic
- metabolic
- immune
- biomarkers
- personalized medicine
- primary cells
- small-molecule inhibitor
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
